523 related articles for article (PubMed ID: 11082721)
1. [Role of carboplatin in the treatment of lung cancer].
Bréchot JM
Bull Cancer; 2000 Aug; 87 Spec No():34-9. PubMed ID: 11082721
[TBL] [Abstract][Full Text] [Related]
2. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A
Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655
[TBL] [Abstract][Full Text] [Related]
3. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R
Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402
[TBL] [Abstract][Full Text] [Related]
5. A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
Seiwert TY; Connell PP; Mauer AM; Hoffman PC; George CM; Szeto L; Salgia R; Posther KE; Nguyen B; Haraf DJ; Vokes EE
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):515-22. PubMed ID: 17255273
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in chemotherapy for lung cancer.
Lilenbaum RC
Curr Opin Pulm Med; 1996 Jul; 2(4):285-9. PubMed ID: 9363153
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma.
Nguyen NP; Leonardo JM; Karlsson U; Vos P; Bullock L; Thomas P; Lepera P; Ludin A; Chu C; Salehpour M; Jendrasiak G; Sallah S
Anticancer Res; 2002; 22(6B):3429-35. PubMed ID: 12552935
[TBL] [Abstract][Full Text] [Related]
8. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L
Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
[TBL] [Abstract][Full Text] [Related]
9. Use of daily low-dose carboplatin in radiotherapy for non-small cell lung cancer.
Satoh H; Ohara K; Fuji H; Ishikawa H; Yamashita YT; Kamma H; Ohtsuka M; Hasegawa S
Anticancer Res; 1998; 18(6B):4625-7. PubMed ID: 9891530
[TBL] [Abstract][Full Text] [Related]
10. A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC).
Cohen RB; Langer CJ; Simon GR; Eisenberg PD; Hainsworth JD; Madajewicz S; Cosgriff TM; Pierce K; Xu H; Liau K; Healey D
Cancer Chemother Pharmacol; 2007 Jun; 60(1):81-9. PubMed ID: 17031646
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy and radiation therapy in lung cancer.
Sause WT
Semin Oncol; 1994 Jun; 21(3 Suppl 6):72-8. PubMed ID: 8052877
[TBL] [Abstract][Full Text] [Related]
12. A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial.
Ichiki M; Kawasaki M; Takayama K; Ninomiya K; Kuba M; Iwami F; Miyazaki N; Oishi K; Takeo S; Aizawa H; Nakanishi Y
Cancer Chemother Pharmacol; 2006 Sep; 58(3):368-73. PubMed ID: 16395589
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy in cancer of the lung].
Gütz S
MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
[TBL] [Abstract][Full Text] [Related]
14. Carboplatin for small cell lung cancer: progress toward greater efficacy and reduced toxicity.
Raghavan D; Perez R; Creaven P; Takita H; Loewen G; Vaickus L
Semin Oncol; 1994 Jun; 21(3 Suppl 6):1-8. PubMed ID: 8052868
[TBL] [Abstract][Full Text] [Related]
15. Weekly paclitaxel and carboplatin with concurrent radiation therapy in locally advanced non-small cell lung cancer: phase I study.
Endo M; Takada Y; Obayashi K; Kotani Y; Satouchi M; Kado T; Sugimura K
Radiat Med; 2005 Aug; 23(5):331-5. PubMed ID: 16342905
[TBL] [Abstract][Full Text] [Related]
16. Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812).
Atagi S; Kawahara M; Tamura T; Noda K; Watanabe K; Yokoyama A; Sugiura T; Senba H; Ishikura S; Ikeda H; Ishizuka N; Saijo N;
Jpn J Clin Oncol; 2005 Apr; 35(4):195-201. PubMed ID: 15845568
[TBL] [Abstract][Full Text] [Related]
17. [Trial of combined radiotherapy and chemotherapy (CBDCA) for post-operative non-small cell lung cancer (N2)].
Nakano N; Kishima H; Yamamura N; Ueda S; Kameda Y; Miyagawa M
Gan To Kagaku Ryoho; 1999 May; 26(6):845-7. PubMed ID: 10410157
[No Abstract] [Full Text] [Related]
18. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
Glorieux P; Ortmanns P; Marien S; Degives R; Degraeve D; Potvin M; Grauwels D; Schallier D
Anticancer Res; 2001; 21(2B):1487-94. PubMed ID: 11396237
[TBL] [Abstract][Full Text] [Related]
19. [Current drug therapy of bronchial cancer].
Drings P
Verh Dtsch Ges Inn Med; 1990; 96():228-41. PubMed ID: 1965460
[No Abstract] [Full Text] [Related]
20. [Radiotherapy and integrated treatment in carcinoma of the lung].
Bottero G; Novella V; Spinoglio G
Minerva Med; 1988 Apr; 79(4):275-9. PubMed ID: 2835711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
